Statins Are Associated with Improved Survival of Patients with Gastric Cancer: A Systematic Review and Meta-Analysis. 2022

Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
Department of Clinical Laboratory, Binzhou Medical University, Yantai, Shandong, China.

Statins are associated with gastric cancer (GC) risk. The present study aimed to clarify the efficacy of statins on the overall survival (OS) benefits in patients with GC. Publications were retrieved from PubMed, Embase, and the Cochrane Library as of April 2022. Data from the eligible cohort, case-control studies, and randomized control trials (RCTs) were extracted for the meta-analysis. Hazard ratio (HR) and 95% confidence intervals (CI) were used to assess the association between statins users and OS in GC patients. Subgroup analysis was performed based on the study design (prospective vs. retrospective). A total of 6 studies encompassing 5693 GC patients were included. Statins added to the standard treatment prolonged the patient's OS outcome (HR (95% CI): 0.72 (0.53-0.97), p = 0.032; I 2 = 88.0%, p  < 0.001). A prospective study did not find any statistically significant difference in OS between statins users vs. nonstatin users (HR (95% CI): 0.92 (0.68-1.26), p = 0.614; I 2 = 11.7%, p  = 0.322), whereas the retrospective studies showed prolonged OS in statins users (HR (95% CI): 0.63 (0.42-0.961), p = 0.032; I 2 = 94.6%, p  < 0.001). Statin users had significantly improved OS compared to nonstatin users in GC treatment. This long-term survival benefit was only observed in the pooled analysis of retrospective studies but not in prospective studies.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D016016 Proportional Hazards Models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Cox Model,Cox Proportional Hazards Model,Hazard Model,Hazards Model,Hazards Models,Models, Proportional Hazards,Proportional Hazard Model,Proportional Hazards Model,Cox Models,Cox Proportional Hazards Models,Hazard Models,Proportional Hazard Models,Hazard Model, Proportional,Hazard Models, Proportional,Hazards Model, Proportional,Hazards Models, Proportional,Model, Cox,Model, Hazard,Model, Hazards,Model, Proportional Hazard,Model, Proportional Hazards,Models, Cox,Models, Hazard,Models, Hazards,Models, Proportional Hazard
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA

Related Publications

Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
July 2013, Annals of oncology : official journal of the European Society for Medical Oncology,
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
October 2013, European journal of clinical pharmacology,
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
February 2013, Gastroenterology,
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
December 2022, Journal of clinical medicine,
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
January 2023, Gastroenterology and hepatology from bed to bench,
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
June 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
October 2008, European journal of cancer (Oxford, England : 1990),
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
June 2021, Atherosclerosis,
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
September 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
Mingjie Yuan, and Shuyi Han, and Yanfei Jia, and Jiankai Feng, and Duanrui Liu, and Zhenguo Su, and Xiangdong Liu
October 2020, Translational cancer research,
Copied contents to your clipboard!